These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 9672772)

  • 1. New prospects in the treatment of indolent lymphomas with purine analogues.
    Cheson BD
    Cancer J Sci Am; 1998 Jul; 4 Suppl 2():S27-36. PubMed ID: 9672772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perspectives on purine analogues.
    Cheson BD
    Hematol Cell Ther; 1996 Dec; 38 Suppl 2():S109-16. PubMed ID: 9137964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia.
    Plosker GL; Figgitt DP
    Drugs; 2003; 63(8):803-43. PubMed ID: 12662126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Second malignancies as a consequence of nucleoside analog therapy for chronic lymphoid leukemias.
    Cheson BD; Vena DA; Barrett J; Freidlin B
    J Clin Oncol; 1999 Aug; 17(8):2454-60. PubMed ID: 10561309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purine analogs in chronic lymphocytic leukemia and Waldenström's macroglobulinemia.
    O'Brien S; Kantarjian H; Keating MJ
    Ann Oncol; 1996; 7 Suppl 6():S27-33. PubMed ID: 9010576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The newer purine analogs. Significant therapeutic advance in the management of lymphoid malignancies.
    Saven A; Piro LD
    Cancer; 1993 Dec; 72(11 Suppl):3470-83. PubMed ID: 7902205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative efficacy of the newer nucleosides (fludarabine, 2'-deoxycoformycin, and 2-chlorodeoxyadenosine) in the treatment of indolent lymphoid malignancies.
    Saven A
    Semin Hematol; 1993 Oct; 30(4 Suppl 6):31-3. PubMed ID: 7908757
    [No Abstract]   [Full Text] [Related]  

  • 8. Purine nucleoside analogs in indolent non-Hodgkin's lymphoma.
    Cabanillas F
    Oncology (Williston Park); 2000 Jun; 14(6 Suppl 2):13-5. PubMed ID: 10887639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purine analogs in the treatment of low-grade lymphomas and chronic lymphocytic leukemias.
    Pott-Hoeck C; Hiddemann W
    Ann Oncol; 1995 May; 6(5):421-33. PubMed ID: 7669706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Purine nucleoside analogues and combination therapies in B-cell chronic lymphocytic leukemia: dawn of a new era.
    Nabhan C; Gartenhaus RB; Tallman MS
    Leuk Res; 2004 May; 28(5):429-42. PubMed ID: 15068894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Purine nucleoside analogues in the treatment of myleoid leukemias.
    Robak T
    Leuk Lymphoma; 2003 Mar; 44(3):391-409. PubMed ID: 12688309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fludarabine and cladribine in relapsed/refractory low-grade non-Hodgkin's lymphoma: a phase II randomized study.
    Tondini C; Balzarotti M; Rampinelli I; Valagussa P; Luoni M; De Paoli A; Santoro A; Bonadonna G
    Ann Oncol; 2000 Feb; 11(2):231-3. PubMed ID: 10761763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New antimetabolites in the treatment of human malignancies.
    Cheson BD
    Semin Oncol; 1992 Dec; 19(6):695-706. PubMed ID: 1361080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purine analogs in lymphoproliferative disorders.
    Cheson BD
    Leuk Lymphoma; 1993; 11 Suppl 2():153-9. PubMed ID: 7907252
    [No Abstract]   [Full Text] [Related]  

  • 15. Cladribine in indolent non-Hodgkin's lymphoma.
    Sigal DS; Saven A
    Expert Rev Anticancer Ther; 2008 Apr; 8(4):535-45. PubMed ID: 18402520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic potential of purine analogue combinations in the treatment of lymphoid malignancies.
    Johnson SA; Thomas W
    Hematol Oncol; 2000 Dec; 18(4):141-153. PubMed ID: 11135355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Purine analogs in the treatment of chronic lymphocytic leukemia.
    Pott C; Hiddemann W
    Leukemia; 1997 Apr; 11 Suppl 2():S25-8. PubMed ID: 9178834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pentostatin in chronic lymphocytic leukemia.
    Sauter C; Lamanna N; Weiss MA
    Expert Opin Drug Metab Toxicol; 2008 Sep; 4(9):1217-22. PubMed ID: 18721115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pentostatin (Nipent) and chlorambucil with granulocyte-macrophage colony-stimulating factor support for patients with previously untreated, treated, and fludarabine-refractory B-cell chronic lymphocytic leukemia.
    Waselenko JK; Grever MR; Beer M; Lucas MA; Byrd JC
    Semin Oncol; 2000 Apr; 27(2 Suppl 5):44-51. PubMed ID: 10877052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurotoxicity of purine analogs: a review.
    Cheson BD; Vena DA; Foss FM; Sorensen JM
    J Clin Oncol; 1994 Oct; 12(10):2216-28. PubMed ID: 7931492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.